Baxter Completes Acquistion of RECOTHROM and PREVELEAK to Broaden Surgical Hemostat and Sealant Portfolio
March 19, 2018
March 19, 2018
DEERFIELD, Illinois, March 19 -- Baxter International, a health care company that focuses on products to treat hemophilia, kidney disease, immune disorders and other chronic and acute medical conditions, issued the following news release:
Baxter International Inc. (NYSE: BAX), a global medical products company, is committed to advancing surgical innovation and today announced it has completed its previously announced acquisition of two hemostat and sealant products from Mallinckrodt . . .
Baxter International Inc. (NYSE: BAX), a global medical products company, is committed to advancing surgical innovation and today announced it has completed its previously announced acquisition of two hemostat and sealant products from Mallinckrodt . . .